Sterically Shielded Heptamethine Cyanine Dyes Against Aggregation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Heptamethine cyanine dyes suffer from dye instability, self-aggregation, and poor pharmacokinetics, limiting their applications in biomedical imaging due to issues like chemical degradation, non-specific interactions, and photobleaching.
Innovation Solution
Development of sterically shielded heptamethine cyanine dyes with a central cyclohexyl ring absent and polyene protected by two arms, preventing self-aggregation and enhancing chemical stability and photostability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If heptamethine cyanine dyes are used for NIR imaging, then deep light penetration and high image contrast are achieved, but dye instability, self-aggregation, and poor pharmacokinetics occur
Solution Approach 1:
The patent removes the central cyclohexyl ring from the traditional heptamethine cyanine dye structure, extracting the problematic hydrophobic core that causes self-aggregation and instability, while retaining the fluorescent polyene chain for imaging functionality
Solution Approach 2:
The patent creates a composite molecular structure by combining the heptamethine polyene fluorescent core with zwitterionic side chains and sterically shielding groups, forming a new class of dyes that integrate multiple functional properties to simultaneously achieve stability and imaging performance
2Reliability
If polyanionic structures like CW800 are used, then pharmacokinetics improve, but non-specific interactions with proteins and cell membranes increase
Solution Approach 1:
The patent changes the charge distribution parameter of the dye molecule by introducing zwitterionic side chains with both positive and negative charges, transforming the overall polyanionic character into a charge-balanced structure that reduces electrostatic non-specific interactions while maintaining favorable pharmacokinetics
3Adaptability or versatility
If meso C-OAryl bonds are used for bioconjugation, then reactive sites are available, but chemical degradation by biological amines and thiols occurs
Solution Approach 1:
The patent introduces sterically shielding groups at specific local positions around the meso C-OAryl bond, creating a protective environment that prevents nucleophilic attack by biological amines and thiols while leaving the reactive site accessible for intended bioconjugation reactions
4Illumination intensity
If electron-rich heptamethine polyenes are used, then fluorescent properties are enhanced, but susceptibility to photobleaching by singlet oxygen increases
Solution Approach 1:
The patent introduces sterically shielding groups that position themselves around the electron-rich heptamethine polyene core before photobleaching can occur, creating a physical barrier that prevents singlet oxygen from accessing and reacting with the vulnerable polyene bonds, thereby cushioning against photodegradation
5Quantity of substance
If rigid hydrophobic cores are used for charge balanced structures, then water solubility improves, but dye self-aggregation increases
Solution Approach 1:
The patent transitions from a two-dimensional planar hydrophobic core structure to a three-dimensional architecture by introducing sterically shielding groups that project above and below the polyene plane, creating a volumetric barrier that prevents the flat-to-flat stacking interactions that drive self-aggregation while maintaining charge-balanced solubility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The shielded dyes exhibit improved photophysical, physiochemical, and biodistribution properties, enabling high-contrast cancer cell microscopy and tumor imaging with a high Tumor-to-Background ratio and ultralow retention in background tissue, suitable for fluorescence-guided surgery.
Implementation Method 1
Fluorescent heptamethine cyanine dyes (known traditionally and commercially as Cy7) have absorption peaks in the near-infrared (NIR) range of 740-840 nm
Data Source
AI summary
The near-infrared window of fluorescent heptamethine cyanine dyes greatly facilitates biological imaging because there is deep penetration of the light and negligible background fluorescence. But dye instability, aggregation, and poor pharmacokinetics are current drawbacks that limit performance and the scope of possible applications. All these limitations are simultaneously overcome with a new molecular design strategy that produces a charge balanced and sterically shielded fluorochrome. The key design feature is a meso-Aryl group that simultaneously projects two shielding arms directly over each face of a linear heptamethine polyene. Cell and mouse imaging experiments compared a shielded heptamethine cyanine dye (and several peptide and antibody bioconjugates) to benchmark heptamethine dyes and found that the shielded systems possess an unsurpassed combination of photophysical, physiochemical and biodistribution properties that greatly enhance bioimaging performance.